Comparing Allergenic Effects of 3 German Cockroach Extracts in Adults
NCT00132847 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2013-01-23
Summary
The purpose of this study is to test and compare the allergenic effects of three commercially available German cockroach allergen extracts in adults.
Study hypothesis: The biological potency of three commercially available German cockroach allergy extracts can be compared using the ID50EAL method to standardize German cockroach allergens.
Conditions
- Asthma
- Allergy
Interventions
- BIOLOGICAL
-
German Cockroach Allergen extract
Sponsors & Collaborators
-
Inner-City Asthma Consortium
collaborator NETWORK -
National Institute of Allergy and Infectious Diseases (NIAID)
lead NIH
Principal Investigators
-
Peyton Eggleston, MD · Johns Hopkins University
-
Jacqueline Pongracic, MD · Ann & Robert H Lurie Children's Hospital of Chicago
-
Stan Szefler, MD · National Jewish Health
-
Floyd Malveaux, MD, PhD · Howard University
-
William W. Busse, MD · University of Wisconsin, Madison
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-04-30
- Completion
- 2004-10-31
More Related Trials
-
Biomarker-based Cockroach Sublingual Immunotherapy Study (BioCSI)
NCT00829985 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover
NCT00972504 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens
NCT00263627 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Stapokibart Injection in Patients With Allergic Rhinitis
NCT06525597 ·Status: RECRUITING ·Phase: PHASE2
-
Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma
NCT00263640 ·Status: COMPLETED ·Phase: PHASE3
-
Biological Standardization of Allergen Extracts of Pollens of Betula Pendula, Phleum Pratense and Mite Extract of Dermatophagoides Pteronyssinus
NCT01147159 ·Status: COMPLETED ·Phase: PHASE2
-
Biological Standardization of Secale Cereale Allergen Extract
NCT01408238 ·Status: COMPLETED ·Phase: PHASE2
-
Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units
NCT00718744 ·Status: COMPLETED ·Phase: PHASE2
-
Allergen Challenge Trial of IRL201104 in Seasonal Allergic Rhinitis
NCT05098522 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
NCT00836914 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose-finding Study of ASP4070
NCT03101267 ·Status: COMPLETED ·Phase: PHASE2
-
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
NCT00791102 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental Chamber
NCT01066611 ·Status: COMPLETED ·Phase: PHASE1
-
Allergen Challenge Chamber Study With Single Dose Oral GSK835726 Compared With Placebo
NCT00851344 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Nasal Carbon Dioxide (CO2) in the Treatment of Seasonal Allergic Rhinitis
NCT00688441 ·Status: COMPLETED ·Phase: PHASE2
-
Study With Rupatadine in Mosquito-Bite Allergic Adult Subjects
NCT00258141 ·Status: UNKNOWN ·Phase: PHASE4
-
Biological Standardization of Dactylis Glomerata Allergen Extract
NCT01407835 ·Status: COMPLETED ·Phase: PHASE2
-
Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).
NCT00917488 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402)
NCT00659750 ·Status: COMPLETED ·Phase: PHASE3
-
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
NCT05532566 ·Status: RECRUITING ·Phase: NA
-
Safety and Efficacy of Grass Pollen Allergoid in the Treatment of Allergic Rhinoconjunctivitis
NCT00263601 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis
NCT00309036 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AL-53817 Nasal Spray Solution
NCT01454505 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Find Out How Long it Takes Azelastine Hydrochloride 0.15% Nasal Spray to Relieve Symptoms in Patients Suffering From Allergic Rhinitis
NCT04264637 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of a Sublingual Specific Immunotherapy With an Extract of a Six Grass Pollen Mixture
NCT00264459 ·Status: COMPLETED ·Phase: PHASE3